The group's billionaire chairman, Gautam Adani, and seven other people were charged with agreeing to pay around $265 million in bribes to Indian government officials
business2 hours ago
German pharmaceutical giant Merck and a US partner reported promising results on Saturday in trials of a drug administered orally to fight Covid-19, saying it helps reduce patients’ viral load.
“At a time where there is unmet need for antiviral treatments against SARS-CoV-2, we are encouraged by these preliminary data,” said Wendy Painter, chief medical officer of the US firm, Ridgeback Biotherapeutics.
In January, Merck halted work on two Covid vaccine candidates but has pressed on with research into two products to treat the disease, including a pill-based one called molnupiravir, which it has developed with Ridgeback Biotherapeutics.
This drug caused a significant drop in patients’ viral load after five days of treatment with it, Merck said at a meeting with infectious disease experts.
This Phase 2a test — drug trials have three stages before a product can be approved — was carried out among 202 non-hospitalized people with symptoms of Covid-19.
There was no alert in terms of safety, and of four serious adverse events that were reported, none were considered to be related to taking this drug, Ridgeback said.
Anti-viral oral drugs such as oseltamivir (Tamiflu) and zanamivir (Relenza) are sometimes prescribed for seasonal flu but researchers have yet to come up with something similar to fight the coronavirus.
The findings of this study — a quicker decrease in viral load among individuals with early-stage Covid-19 who are treated with molnupiravir — are promising, said William Fischer, lead investigator of the study and a professor of medicine at the University of North Carolina.
“If supported by additional studies, (they) could have important public health implications, particularly as the SARS-CoV-2 virus continues to spread and evolve globally,” Fischer added.
Merck is also working on another oral Covid treatment called MK-711.
Preliminary results from clinical trials with it show a more than 50 percent reduction in risk of death or respiratory trouble in patients hospitalized with moderate to severe Covid-19, the company said in January.
The group's billionaire chairman, Gautam Adani, and seven other people were charged with agreeing to pay around $265 million in bribes to Indian government officials
business2 hours ago
Drivers are urged to follow changing speed limits displayed on electronic information boards
weather3 hours ago
Future phases will be announced to include other services for unmanned aerial vehicle, such as flying operations for amateur individuals
uae4 hours ago
Dubai American Academy converts cafeteria food waste into fertiliser after installing a ‘food-to-fertiliser machine’ on its premises
uae4 hours ago
Doctors warn of a visible rise in oral herpes cases among school-aged children in the country especially in the cooler winter months
uae4 hours ago
The 132-storey Burj Azizi, which will stand 725m tall, is scheduled for completion by 2028
realty4 hours ago
On the back of his fabulous innings, the Samp Army managed to chase down the total of 104 set up by Chennai Brave Warriors
cricket8 hours ago
Nine ran in the Nakheel-sponsored contest, including G2 Godolphin Mile runner-up Walk Of Stars, who put up the biggest challenge to the winner
horse racing9 hours ago